跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OSNUVO - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
OSNUVO
Authorized
STANDARD
OSNUVO
avir pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
88fac92cb7a7079b
Company
avir pharma inc.
Type
Standard
Approval Details
Approval Id
88fac92cb7a7079b
Drug Approval Canada Name
OSNUVO
Product Name
OSNUVO
Status
Marketed
Status Date
2020-10-27
Original Market Date
2020-10-27
Din
02495589
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Schedule D , Prescription
Ahfs
68:24.08
Atc Original
H05AA02 TERIPARATIDE
Atc Name
h 05 aa 02
Aig Number
0150152001
Company Name
avir pharma inc.
Company Address
660 Boulevard Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
TERIPARATIDE
250 MCG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
88fac92cb7a7079b
Type
Standard
Back to Health Canada Approvals